| [1] |
Enguita-Germán M,Fortes P.Targeting the insulin-like growth factor pathway in hepatocellular carcinoma[J].World J Hepatol,2014,6(10):716-737.
|
| [2] |
Morise Z,Kawabe N,Tomishige H,et al. Recent advances in the surgical treatment of hepatocellular carcinoma[J]. World J Gastroenterol,2014,20(39):14381-14392.
|
| [3] |
Folkman J.Tumorangiogenesis:therapeutic implication[J]. N Engl J Med,1971,285(21):1182-1186.
|
| [4] |
Dong J,Yao SW,Xu YG.Tumor angiogenesis inhibitors[J]. Prog Chem(化学进展),2010,22(10):1994-2002.
|
| [5] |
Wang JR,Li J,Lu BB,et al.Efficacy of bevacizumab combined with FOLFIRI in the treatment of refractory metatastic colorectal cancer[J].Mod Oncol(现代肿瘤医学),2013,21(3):578-581.
|
| [6] |
Hurwitz H,Fehrenbacher L,Novotny W,et al.Bevacizumab plus irinotecan,fluorouracil and leucovorin for metastatic colorectal cancer[J]. N Engl J Med,2004,350(23):2335-2342.
|
| [7] |
Yang CX,Qin SK.Clinical study progression of oxaliplatin for primary hepaticcarcinoma[J].Chin Clin Oncol(临床肿瘤学杂志),2010,15(9):849-855.
|
| [8] |
Petrelli F,Coinu A,Borgonovo K,et al.Oxaliplatin-based chemotherapy:a new option in advanced hepatocellular carcinoma.A systematic review and pooled analysis[J].J Clin Oncol,2014, 26(8):488-496.
|
| [9] |
Weidner N,Semple JP,Welch WR,et al.Tumor angiogenesis and metastasis correlation in invasive breast carcinoma[J].N Engl J Med,1991,324(1):1-8.
|
| [10] |
Bai LM,Huang XF,Xu HM.Investigation of microvessel density and related factors expression for xenografts tumor of HT29 cells in nude mice at different growth stage[J].Chin Pharmacol Bull(中国药理学报),2014,30(6):796-800.
|
| [11] |
Xv DZ.Evaluation of the combined effect of drugs[J].Prog Physiol Sci(生理科学进展),1992,23(3):248-253.
|
| [12] |
Jin ZJ,Zhang XW.Equi-probability sum curves and “Q50”[J].J Shanghai Second Hosp(上海第二医院学报),1981,1(1):15-18.
|
| [13] |
Abdel-Rahman O. Revisiting oxaliplatin-based regimens for advanced hepatocellular carcinoma[J].Curr Oncol Rep,2014,16(8):394.
|
下载:
